• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NAFLD-related mortality: simple hepatic steatosis is not as 'benign' as thought.

作者信息

Tilg Herbert, Targher Giovanni

机构信息

Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria

Endocrinology and Metabolism, University of Verona, Ospedale Civile Maggiore, Verona, Italy.

出版信息

Gut. 2021 Jul;70(7):1212-1213. doi: 10.1136/gutjnl-2020-323188. Epub 2020 Oct 19.

DOI:10.1136/gutjnl-2020-323188
PMID:33077572
Abstract
摘要

相似文献

1
NAFLD-related mortality: simple hepatic steatosis is not as 'benign' as thought.非酒精性脂肪性肝病相关死亡率：单纯性肝脂肪变性并非如人们所想的那样“良性”。
Gut. 2021 Jul;70(7):1212-1213. doi: 10.1136/gutjnl-2020-323188. Epub 2020 Oct 19.
2
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.非酒精性脂肪性肝炎与非肝硬化患者亚临床心肌功能障碍的相关性。
J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24.
3
[The harmfulness of simple steatosis].
Dtsch Med Wochenschr. 2021 Feb;146(3):146-151. doi: 10.1055/a-1156-0875. Epub 2021 Jan 29.
4
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).非酒精性脂肪性肝病（NAFLD）和酒精性相关脂肪性肝病（AFLD）患者的死亡原因。
Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231.
5
Liver sympathetic denervation reverses obesity-induced hepatic steatosis.肝交感神经去神经支配可逆转肥胖诱导的肝脂肪变性。
J Physiol. 2019 Sep;597(17):4565-4580. doi: 10.1113/JP277994. Epub 2019 Jul 26.
6
Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.激活转录因子 3 是连接肝脂肪变性与葡萄糖稳态受损的靶分子。
J Hepatol. 2017 Aug;67(2):349-359. doi: 10.1016/j.jhep.2017.03.023. Epub 2017 Mar 30.
7
[Descriptive study of hepatic steatosis and associated morbidity in Primary Care. (ESTEATOAP Study)].[基层医疗中肝脂肪变性及其相关发病率的描述性研究。（ESTEATOAP研究）]
Semergen. 2020 Sep;46(6):400-405. doi: 10.1016/j.semerg.2020.01.003. Epub 2020 Apr 2.
8
Human germline hedgehog pathway mutations predispose to fatty liver.人类种系 hedgehog 信号通路突变易导致脂肪肝。
J Hepatol. 2017 Oct;67(4):809-817. doi: 10.1016/j.jhep.2017.06.008. Epub 2017 Jun 21.
9
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.酒精性或非酒精性脂肪性肝病中，超声评估的受控衰减参数与肝脂肪变性之间的关系
Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155.
10
Prolactin improves hepatic steatosis via CD36 pathway.催乳素通过 CD36 途径改善肝脂肪变性。
J Hepatol. 2018 Jun;68(6):1247-1255. doi: 10.1016/j.jhep.2018.01.035. Epub 2018 Feb 13.

引用本文的文献

1
The potential mechanisms of reciprocal regulation of gut microbiota-liver immune signaling in metabolic dysfunction-associated steatohepatitis revealed in multi-omics analysis.多组学分析揭示代谢功能障碍相关脂肪性肝炎中肠道微生物群与肝脏免疫信号相互调节的潜在机制。
mSystems. 2025 Jul 22;10(7):e0051825. doi: 10.1128/msystems.00518-25. Epub 2025 Jun 10.
2
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距：欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
3
Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification.
基于网络药理学分析和实验验证的疏肝益脾颗粒抗非酒精性脂肪性肝病作用机制研究
Heliyon. 2024 Aug 5;10(15):e35491. doi: 10.1016/j.heliyon.2024.e35491. eCollection 2024 Aug 15.
4
Integrated Pharmaco-Bioinformatics Approaches and Experimental Verification To Explore the Effect of Britanin on Nonalcoholic Fatty Liver Disease.整合药物生物信息学方法与实验验证以探究大花旋覆花素对非酒精性脂肪性肝病的影响
ACS Omega. 2024 Feb 9;9(7):8274-8286. doi: 10.1021/acsomega.3c08968. eCollection 2024 Feb 20.
5
The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase.BTRC 在脂肪变性中作为 ATGL E3 连接酶的关键作用。
J Mol Cell Biol. 2024 Apr 4;15(10). doi: 10.1093/jmcb/mjad064.
6
Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease.探究代谢表型对酒精性和非酒精性脂肪性肝病健康事件的影响。
J Clin Transl Hepatol. 2023 Jun 28;11(3):525-533. doi: 10.14218/JCTH.2022.00214. Epub 2023 Jan 4.
7
Liver stiffness (Fibroscan®) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease.肝脏硬度（Fibroscan®）可预测非酒精性脂肪性肝病患者的全因死亡率。
Liver Int. 2023 Jan;43(1):90-99. doi: 10.1111/liv.15415. Epub 2022 Sep 27.
8
Efficacy and mechanism of Jiedu Tongluo Tiaogan Formula in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease: Study protocol for a parallel-armed, randomized controlled trial.解毒通络调肝方治疗2型糖尿病合并非酒精性脂肪性肝病的疗效及机制：一项平行双臂随机对照试验的研究方案
Front Pharmacol. 2022 Aug 12;13:924021. doi: 10.3389/fphar.2022.924021. eCollection 2022.
9
Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.银屑病关节炎患者非酒精性脂肪性肝病的免疫危险因素：新的预测列线图和自然杀伤细胞。
Front Immunol. 2022 Jul 22;13:907729. doi: 10.3389/fimmu.2022.907729. eCollection 2022.
10
Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population.用于预测中国人群非酒精性脂肪性肝病筛查中受控衰减参数值的简易替代方程。
Front Med (Lausanne). 2022 Jul 22;9:894895. doi: 10.3389/fmed.2022.894895. eCollection 2022.